Richard T. Meehan

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1K citations · Full text

Sls Ii, Mycophenolate Mofetil, Inflammatory Lung Disease +9

Toll-like receptor 7 (TLR7)–driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity

Anatoly V. Rubtsov, Kira Rubtsova, Aryeh Fischer et al. · Blood · 2011 · 775 citations · Full text

Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease

Aryeh Fischer, Kevin K. Brown, Roland M. du Bois et al. · The Journal of Rheumatology · 2013 · 389 citations · Full text

Rheumatoid Arthritis–related Lung Diseases: CT Findings

Nobuyuki Tanaka, Jeung Sook Kim, John D. Newell et al. · Radiology · 2004 · 344 citations

Mycophenolate Mofetil Is Safe, Well Tolerated, and Preserves Lung Function in Patients With Connective Tissue Disease-Related Interstitial Lung Disease

Jeffrey J. Swigris, Amy L. Olson, Aryeh Fischer et al. · CHEST Journal · 2006 · 180 citations

Antifibrotic Therapy, Inflammatory Lung Disease, Advanced Lung Disease +7